Stefano Sammicheli
Overview
Explore the profile of Stefano Sammicheli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loyau J, Monney T, Montefiori M, Bokhovchuk F, Streuli J, Blackburn M, et al.
MAbs
. 2025 Jan;
17(1):2457471.
PMID: 39882744
ISB 1442 is a bispecific biparatopic antibody in clinical development to treat hematological malignancies. It consists of two adjacent anti-CD38 arms targeting non-overlapping epitopes that preferentially drive binding to tumor...
2.
Giampazolias E, Schulz O, Lim K, Rogers N, Chakravarty P, Srinivasan N, et al.
Cell
. 2021 Jun;
184(15):4016-4031.e22.
PMID: 34081922
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells (cDC1s) is thought to underlie priming of anti-cancer CD8 T cells. cDC1 express high levels of DNGR-1...
3.
Cremasco F, Menietti E, Speziale D, Sam J, Sammicheli S, Richard M, et al.
PLoS One
. 2021 Jan;
16(1):e0241091.
PMID: 33406104
Diffuse large B cell lymphomas (DLBCL) are a highly heterogeneous subtype of Non Hodgkin Lymphoma (NHL), accounting for about 25% of NHL. Despite an increased progression-free survival upon therapy, 40-50%...
4.
Mayoux M, Roller A, Pulko V, Sammicheli S, Chen S, Sum E, et al.
Sci Transl Med
. 2020 Mar;
12(534).
PMID: 32161104
PD-L1/PD-1 blocking antibodies have demonstrated therapeutic efficacy across a range of human cancers. Extending this benefit to a greater number of patients, however, will require a better understanding of how...
5.
Vo H, Baudner B, Sammicheli S, Iannacone M, DOro U, Piccioli D
Front Immunol
. 2018 Apr;
9:641.
PMID: 29686670
Vaccination is one of the most cost-effective health interventions and, with the exception of water sanitization, no other action has had such a major effect in mortality reduction. Combined with...
6.
Sammicheli S, Kuka M, Iannacone M
Methods Mol Biol
. 2018 Feb;
1763:63-74.
PMID: 29476489
Humoral immune responses depend on B cells encountering antigen (Ag) in lymph nodes (LNs) draining infection sites, getting activated, interacting with different cells, proliferating and differentiating into antibody (Ab)-secreting cells....
7.
Bottcher J, Bonavita E, Chakravarty P, Blees H, Cabeza-Cabrerizo M, Sammicheli S, et al.
Cell
. 2018 Feb;
172(5):1022-1037.e14.
PMID: 29429633
Conventional type 1 dendritic cells (cDC1) are critical for antitumor immunity, and their abundance within tumors is associated with immune-mediated rejection and the success of immunotherapy. Here, we show that...
8.
Sammicheli S, Kuka M, Di Lucia P, Jimenez de Oya N, De Giovanni M, Fioravanti J, et al.
Sci Immunol
. 2016 Nov;
1(4).
PMID: 27868108
Antibodies are critical for protection against viral infections. However, several viruses, such as lymphocytic choriomeningitis virus (LCMV), avoid the induction of early protective antibody responses by poorly understood mechanisms. Here...
9.
Lantto R, Nasi A, Sammicheli S, Amu S, Fievez V, Moutschen M, et al.
AIDS
. 2015 Aug;
29(14):1757-66.
PMID: 26262581
Objective: CD70 molecules expressed by activated T cells provide potent B cell stimulatory signals. We hypothesized that an altered CD70 expression might contribute to B cell abnormalities during HIV-1 infection....
10.
Guidotti L, Inverso D, Sironi L, Di Lucia P, Fioravanti J, Ganzer L, et al.
Cell
. 2015 Apr;
161(3):486-500.
PMID: 25892224
Effector CD8(+) T cells (CD8 TE) play a key role during hepatotropic viral infections. Here, we used advanced imaging in mouse models of hepatitis B virus (HBV) pathogenesis to understand...